LSD1-IN-27 structure
|
Common Name | LSD1-IN-27 | ||
|---|---|---|---|---|
| CAS Number | 2904571-94-2 | Molecular Weight | 355.48 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H25N3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LSD1-IN-27LSD1-IN-27 (Compound 5ac) is a LSD1 inhibitor (IC50: 13 nM). LSD1-IN-27 inhibits the stemness and migration of gastric cancer cells. LSD1-IN-27 also reduces the expression of PD-L1 in BGC-823 and MFC cells. LSD1-IN-27 can enhance T cell immune response in gastric cancer[1]. |
| Name | LSD1-IN-27 |
|---|
| Description | LSD1-IN-27 (Compound 5ac) is a LSD1 inhibitor (IC50: 13 nM). LSD1-IN-27 inhibits the stemness and migration of gastric cancer cells. LSD1-IN-27 also reduces the expression of PD-L1 in BGC-823 and MFC cells. LSD1-IN-27 can enhance T cell immune response in gastric cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
13 nM (LSD1)[1] |
| References |
| Molecular Formula | C24H25N3 |
|---|---|
| Molecular Weight | 355.48 |
| InChIKey | COFJGRODNLNWAE-UHFFFAOYSA-N |
| SMILES | Cc1ccc2nc3c(C)c(C)ccc3c(Nc3ccc(N(C)C)cc3)c2c1 |